Omega Diagnostics suffers infectious disease test setback
7th Jul 2015 09:37
Shares in Omega Diagnostics were hit hard by the allergy and disease testing company's admission that field tests of its much-anticipated Visitect CD4 test for infectious diseases were likely to be delayed by a stability issue. Although chairman David Evans announced preliminary results for the year
Read moreOmega Diagnostics reports good progress in infectious disease division
1st Jun 2015 12:00
AIM-listed medical diagnostics company Omega has cheered with news of its infectious disease and allergy projects. Within infectious disease it has made three pilot batches of test devices all of which have shown that its Visitect CD4 product is capable of meeting its performance design goals in com
Read moreOmega Diagnostics generates alpha with encouraging update
15th Apr 2015 10:05
Shares in Omega Diagnostics were seen as a better investment on Wednesday after a trading update indicated full-year results will be ahead of target and revealed encouraging developments with the product portfolio. The AIM-listed company believes it has identified the cause of the manufacturing vari
Read moreOmega Diagnostics develops new app for health services partnership
1st Jul 2014 11:29
Omega Diagnostics has helped form a new group to connect the mobile and health industries to help meet public health needs in rural areas. As part of the Groupe Speciale Mobile Association (GSMA), Omega can offer use of its mobile app, CD4, to transmit HIV test results from remote villages in Sub-S
Read moreOmega Diagnostics' full-year results meet targets
23rd Jun 2014 07:37
- Adjusted pre-tax profit surges 41% - Strong performance from food intolerance division - Positive about future prospects Medical diagnostics company Omega reported a surge in full-year adjusted pre-tax profit after a robust performance from its food intolerance division and said it remains positi
Read moreOmega Diagnostics makes progress with HIV blood test
13th Feb 2014 11:20
Shares in Omega Diagnostics rose after the medical group said it had passed a major milestone in developing its Visitect CD4 HIV blood test. The stock lifted 2.75p, or more than 16%, to 19.5p by 11:44 in London as Omega said it had completed the technology transfer phase for Visitect CD4, which ens
Read moreOmega hurt by weak UK, European markets
1st Jul 2013 07:53
Medical diagnostics firm Omega said full year profit tumbled 22 per cent following a slowdown in growth in European markets. Adjusted profit before tax fell to £0.78m in the year to the end of March from £1.0m in 2012. Annual turnover was little changed at £11.3m compared to £11.1m previously. Gr
Read moreOmega Diagnostics raises funds for research and development
24th May 2013 09:21
Medical company Omega Diagnostics Group has raised four million pounds through the placement of over 23m shares which will be used to fund the development of new products. The company, focused on developing diagnostics for allergies, food intolerances and infectious diseases, said it intends to use
Read moreOmega Diagnostics awarded grant for HIV test
19th Nov 2012 15:04
Omega Diagnostics has been awarded a grant of up to 150,000 pounds from Scottish Enterprise to help scale up manufacturing facilities for the company's new CD4 test for monitoring HIV positive patients. The facility will be located at the company's headquarters in Alva, Central Scotland and the gr
Read moreOmega Diagnostics unveils strong year
2nd Jul 2012 16:42
Medical diagnostics group Omega Diagnostics posted a strong set of full year results which saw turnover rise 41 per cent and gross profit leap 49 per cent. Pre-tax profits came in at £0.48m (2011: £0.12m) on revenues of £11.1m, compared with £7.9m the previous year. Earning per share rose from 0.1
Read moreSmall caps round-up: Omega Diagnostics, Oxford Biomedica, i-design ...
16th Apr 2012 10:58
The cash-point marketing company i-design said that revenues for the first half of its current financial year will be ahead of the same period of 2011. The group creates advertising solutions for banks and third parties through cash-point screens. A new contract with a Canadian bank has boosted turn
Read moreOmega Diagnostics grows profit by 53%
26th Nov 2010 15:49
Omega Diagnostics has pushed up its interim profit and there will be more to come when it completes the acquisition of a Germany-based allergy testing business. Revenues grew from £2.87m to £3.3m in the six months to September 2010, while underlying profit jumped from £263,000 to £403,000. That pro
Read moreSmall caps round-up: Judges Scientific, Media Corp, Omeda Diagnostics...
17th Nov 2010 14:31
Scientific instruments designer Judges Scientific revealed that trading has continued to be "favourable" and adjusted earnings in respect of 2010 are likely to exceed current market expectations. Additionally, gas purifier and calibration equipment provider Sircal Instruments, acquired in March, has
Read moreSmall caps round-up: Tri-Star
13th Oct 2010 15:17
Mining company Tri-Star has entered into an agreement with a Turkish contractor to undertake a 17-hole diamond drilling programme of the company's Goynuk antimony mine. Shares in Omega Diagnostics, which specialises in the diagnosis of diseases such as syphilis and TB, soared 16% after it reporte
Read moreSmall caps round-up: Judges Scientific, Terra Catalyst, DCC
16th Jul 2010 11:42
Judges Scientific said trading activity during the six-month ended 30 June remained robust and benefited from a healthy opening order book, strong order intake and favourable exchange rates. Order intake during the half-year was much stronger than in the comparable period of 2009. Terra Catalyst Fu
Read more